The University of New Mexico Comprehensive Cancer Center

Albuquerque, New Mexico 87131

3 studies enrolling now · 5 studies all time

What they study most

Advanced Solid Tumors, Gastric Cancer, Gastroesophageal Junction Cancer, HER2-positive Gastric Cancer, Lymphoma, Non-Hodgkin, Metastatic Breast Cancer, Metastatic Head and Neck Cancer, Multiple Myeloma, Recurrent Head and Neck Cancer, Small Cell Lung Cancer, Unresectable Head and Neck Squamous Cell Carcinoma

Studies at this site

• A Clinical Trial Investigating the Safety, Tolerability, and Therapeutic Effects of BNT113 in Combination With Pembrolizumab Versus Pembrolizumab Alone for Patients With a Form of Head and Neck Cancer Positive for Human Papilloma Virus 16 and Expressing the Protein PD-L1 — Recruiting now
• The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study — Recruiting now
• TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer — Recruiting now
• Combination Margetuximab, Retifanlimab, Tebotelimab, and Chemotherapy Phase 2/3 Trial in HER2+ Gastric/GEJ Cancer — Completed
• Dinutuximab and Irinotecan Versus Irinotecan to Treat Subjects With Relapsed or Refractory Small Cell Lung Cancer — Completed